Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy

Richard F. Otten, Adrian C. Dusa, Mithilesh K. Das

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Brugada pattern ECG changes have been described in various disease states and drug therapies, including electrolyte abnormalities, myocardial pathology, medications, and mechanical abnormalities. Therefore, the diagnosis of Brugada syndrome cannot be made in the presence of confounding variables according to prevailing guidelines. We present a case report which illustrates two important principles regarding Brugada syndrome, the dynamic ECG manifestations and the elimination of confounding variables (in this case significant coronary artery disease and cholinergic pharmacotherapy) prior to definitive diagnosis.

Original languageEnglish (US)
Pages (from-to)1039-1042
Number of pages4
JournalPACE - Pacing and Clinical Electrophysiology
Volume30
Issue number8
DOIs
StatePublished - Aug 1 2007

Fingerprint

Parasympathomimetics
Brugada Syndrome
Coronary Artery Disease
Confounding Factors (Epidemiology)
Drug Therapy
Cholinergic Agents
Electrolytes
Electrocardiography
Guidelines
Pathology

Keywords

  • Brugada syndrome
  • Coronary artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy. / Otten, Richard F.; Dusa, Adrian C.; Das, Mithilesh K.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 30, No. 8, 01.08.2007, p. 1039-1042.

Research output: Contribution to journalArticle

@article{20455f4e6b6d4bda80e3e846d0ecf94c,
title = "Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy",
abstract = "Brugada pattern ECG changes have been described in various disease states and drug therapies, including electrolyte abnormalities, myocardial pathology, medications, and mechanical abnormalities. Therefore, the diagnosis of Brugada syndrome cannot be made in the presence of confounding variables according to prevailing guidelines. We present a case report which illustrates two important principles regarding Brugada syndrome, the dynamic ECG manifestations and the elimination of confounding variables (in this case significant coronary artery disease and cholinergic pharmacotherapy) prior to definitive diagnosis.",
keywords = "Brugada syndrome, Coronary artery disease",
author = "Otten, {Richard F.} and Dusa, {Adrian C.} and Das, {Mithilesh K.}",
year = "2007",
month = "8",
day = "1",
doi = "10.1111/j.1540-8159.2007.00808.x",
language = "English (US)",
volume = "30",
pages = "1039--1042",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy

AU - Otten, Richard F.

AU - Dusa, Adrian C.

AU - Das, Mithilesh K.

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Brugada pattern ECG changes have been described in various disease states and drug therapies, including electrolyte abnormalities, myocardial pathology, medications, and mechanical abnormalities. Therefore, the diagnosis of Brugada syndrome cannot be made in the presence of confounding variables according to prevailing guidelines. We present a case report which illustrates two important principles regarding Brugada syndrome, the dynamic ECG manifestations and the elimination of confounding variables (in this case significant coronary artery disease and cholinergic pharmacotherapy) prior to definitive diagnosis.

AB - Brugada pattern ECG changes have been described in various disease states and drug therapies, including electrolyte abnormalities, myocardial pathology, medications, and mechanical abnormalities. Therefore, the diagnosis of Brugada syndrome cannot be made in the presence of confounding variables according to prevailing guidelines. We present a case report which illustrates two important principles regarding Brugada syndrome, the dynamic ECG manifestations and the elimination of confounding variables (in this case significant coronary artery disease and cholinergic pharmacotherapy) prior to definitive diagnosis.

KW - Brugada syndrome

KW - Coronary artery disease

UR - http://www.scopus.com/inward/record.url?scp=34547575778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547575778&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.2007.00808.x

DO - 10.1111/j.1540-8159.2007.00808.x

M3 - Article

C2 - 17669093

AN - SCOPUS:34547575778

VL - 30

SP - 1039

EP - 1042

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 8

ER -